CIK 0001077183
- Large accelerated filer
NEOGENOMICS INC
Sign in to watch- Ticker
- NEO
- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 742897368
- Phone
- +1 239-768-0600
- Business address
- 9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
- Former names
- AMERICAN COMMUNICATIONS ENTERPRISES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-26 | Bonello William Chief Strategy Officer | Exercise or conversion | +40,166 | $8.03 | $323K | 40,166 |
| 2019-02-26 | Bonello William Chief Strategy Officer | Exercise or conversion | +20,037 | $7.52 | $151K | 60,203 |
| 2019-02-26 | Bonello William Chief Strategy Officer | Sale | −60,203 | $18.90 | $1.1M | 0 |
| 2019-02-26 | Bonello William Chief Strategy Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,166 | 80,334 | ||
| 2019-02-26 | Bonello William Chief Strategy Officer | Exercise or conversion · Stock Option (Right to Buy) | −20,037 | 79,963 | ||
| 2019-02-26 | HIPP RAYMOND R Director | Exercise or conversion | +10,000 | $4.78 | $48K | 297,580 |
| 2019-02-26 | HIPP RAYMOND R Director | Exercise or conversion | +5,556 | $9.11 | $51K | 303,136 |
| 2019-02-26 | HIPP RAYMOND R Director | Exercise or conversion | +3,333 | $7.27 | $24K | 306,469 |
| 2019-02-26 | HIPP RAYMOND R Director | Sale | −18,889 | $18.90 | $357K | 287,580 |
| 2019-02-26 | HIPP RAYMOND R Director | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2019-02-26 | HIPP RAYMOND R Director | Exercise or conversion · Stock Option (Right to Buy) | −5,556 | 2,777 | ||
| 2019-02-26 | HIPP RAYMOND R Director | Exercise or conversion · Stock Option (Right to Buy) | −3,333 | 6,667 | ||
| 2018-12-21 | Johnson Kevin C Director | Purchase | +26,000 | $11.60 | $302K | 103,866 |
| 2018-12-14 | GENERAL ELECTRIC CO Former 10% Owner | Sale | −10,835,145 | $12.00 | $130.0M | 0 |
| 2018-12-12 | Weiss Lawrence Martin Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | $13.87 | $347K | 25,000 |
| 2018-11-19 | TETRAULT LYNN A. Director | Sale | −11,000 | $16.00 | $176K | 40,234 |
| 2018-11-19 | TETRAULT LYNN A. Director | Sale | −2,000 | $15.97 | $32K | 38,234 |
| 2018-11-15 | TETRAULT LYNN A. Director | Exercise or conversion | +10,000 | $6.66 | $67K | 47,346 |
| 2018-11-15 | TETRAULT LYNN A. Director | Exercise or conversion | +5,555 | $9.11 | $51K | 52,901 |
| 2018-11-15 | TETRAULT LYNN A. Director | Exercise or conversion | +3,333 | $7.27 | $24K | 56,234 |
Page 42 of 51 · 1,005 trades